BMYB34 Anleihen
Unten befindet sich eine Liste von BRISTOLMYERSDRN Unternehmensanleihen. Investoren entscheiden sich oft für Unternehmensanleihen, weil sie eine gesteigerte Stabilität zu Zeiten von erheblichen Marktvolatilitäten bieten. Sehen Sie sich die Preise, Renditen und weitere Daten an. Entdecken Sie eine zuverlässige Investition.
Symbol | YTM % | Volumen | Preis % | Coupon % | Verfallsdatum | Ausstehend | Nennwert | Min. Anlagebetrag | Emittent |
|---|---|---|---|---|---|---|---|---|---|
| BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,45% | 15 K | 86,00% | 5,25% | 2043-08-15 | 4,064 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
 BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097 | 6,02% | 30 K | 119,38% | 6,88% | 2097-08-01 | 62,417 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 5,94% | 40 K | 87,86% | 5,00% | 2045-08-15 | 15,709 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,92% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,299 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5,89% | 100 K | 78,85% | 4,35% | 2047-11-15 | 13,567 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122EC8BRIST.MYERS 23/63 | 5,69% | 0 | 113,18% | 6,40% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5,67% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,204 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122EL8BRIST.MYERS 24/64 | 5,60% | 0 | 100,93% | 5,65% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EB0BRIST.MYERS 23/53 | 5,53% | 0 | 111,62% | 6,25% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EK0BRIST.MYERS 24/54 | 5,45% | 0 | 101,57% | 5,55% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043 | 5,43% | 620 K | 97,72% | 5,25% | 2043-08-15 | 218,373 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5754772Bristol-Myers Squibb Company FRN 20-FEB-2026 | 5,40% | 358 K | 100,21% | 5,57% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 5,39% | 50 K | 90,21% | 4,63% | 2044-05-15 | 3,691 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047 | 5,33% | 225 K | 85,97% | 4,35% | 2047-11-15 | 1,236 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EJ3BRIST.MYERS 24/44 | 5,33% | 0 | 102,23% | 5,50% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BRMGBRISTOL-MYERS 13/44 | 5,31% | 0 | 89,67% | 4,50% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040 | 5,29% | 9 K | 104,58% | 5,70% | 2040-10-15 | 151,011 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044 | 5,29% | 97 K | 91,42% | 4,63% | 2044-05-15 | 744,719 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY3883364Bristol-Myers Squibb Company 3.25% 01-AUG-2042 | 5,29% | 366 K | 75,38% | 3,25% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 5,29% | 398 K | 96,14% | 5,00% | 2045-08-15 | 741,723 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 5,27% | 937 K | 89,56% | 4,55% | 2048-02-20 | 1,235 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 5,25% | 7,475 M | 84,88% | 4,25% | 2049-10-26 | 3,749 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122AP3BRISTOL-MYERS 2036 | 5,20% | 0 | 106,16% | 5,88% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DX3BRIST.MYERS 22/62 | 5,19% | 0 | 75,52% | 3,90% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DW5BRIST.MYERS 22/52 | 5,19% | 0 | 76,19% | 3,70% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DV7BRIST.MYERS 22/42 | 5,17% | 0 | 80,54% | 3,55% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 5,14% | 11,855 M | 89,25% | 4,13% | 2039-06-15 | 1,996 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038 | 5,13% | 20 K | 110,00% | 6,13% | 2038-05-01 | 219,255 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DR6BRIST.MYERS 20/40 | 5,12% | 0 | 68,52% | 2,35% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DS4BRIST.MYERS 20/50 | 5,03% | 0 | 60,93% | 2,55% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,00% | 50 K | 95,66% | 3,45% | 2027-11-15 | 16,548 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122EH7BRIST.MYERS 24/34 | 4,97% | 0 | 101,74% | 5,20% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DZ8BRIST.MYERS 23/33 | 4,94% | 0 | 107,11% | 5,90% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DY1BRIST.MYERS 23/31 | 4,79% | 0 | 105,22% | 5,75% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DU9BRIST.MYERS 22/32 | 4,78% | 0 | 88,54% | 2,95% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EG9BRIST.MYERS 24/31 | 4,73% | 0 | 102,01% | 5,10% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,69% | 52 K | 97,60% | 3,90% | 2028-02-20 | 43,838 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| US110122ED6BRIST.MYERS 24/26 | 4,57% | 0 | 100,47% | 4,95% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | 4,55% | 7,407 M | 95,10% | 3,40% | 2029-07-26 | 2,373 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EF1BRIST.MYERS 24/29 | 4,54% | 0 | 101,40% | 4,90% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030 | 4,53% | 2,775 M | 83,69% | 1,45% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122EE4BRIST.MYERS 24/27 | 4,49% | 0 | 100,89% | 4,90% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | 4,45% | 1,896 M | 98,33% | 3,90% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| US110122DP0BRIST.MYERS 20/27 | 4,43% | 0 | 90,68% | 1,13% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007341Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 4,42% | 6,78 M | 98,13% | 3,20% | 2026-06-15 | 1,744 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BRMJBRISTOL-MYERS 17/27 | 4,37% | 0 | 97,54% | 3,25% | 2027-02-27 | 512,277 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | 4,34% | 510 K | 97,48% | 3,45% | 2027-11-15 | 517,675 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY5007345Bristol-Myers Squibb Company 3.875% 15-AUG-2025 | 4,32% | 18 K | 99,56% | 3,88% | 2025-08-15 | 228,734 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026 | 4,21% | 75 K | 105,00% | 6,80% | 2026-11-15 | 255,948 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. |
| BMY5077466Bristol-Myers Squibb Company 0.75% 13-NOV-2025 | 4,15% | 816 K | 96,65% | 0,75% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| XS122674851BRISTOL-MYERS 15/35 | 3,20% | 0 | 86,98% | 1,75% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. |
| BMY4831828Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 2,64% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4933148Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 2,47% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4931963Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 2,47% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4831826Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 2,30% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BRMHBRISTOL-MYERS 15/25 | 1,94% | 0 | 99,07% | 1,00% | 2025-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. |
| BMY4831822Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 0,52% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,953 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4831824Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | −0,13% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,556 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4945645Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | −1,13% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |
| BMY4926518Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | −1,35% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |